Real-time enrollment status for this core binding factor acute myeloid leukemia clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 7:51 PM UTC
| NCT Number | NCT06917911 |
| Recruiting Status | Recruiting |
| Condition | Core Binding Factor Acute Myeloid Leukemia |
| Phase | PHASE2 |
| Target Enrollment | 162 participants |
| Active Locations | 51 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | August 28, 2026 (19 hours ago) |
As of August 28, 2026: Clinical trial NCT06917911 is currently recruiting participants. This phase2 study for core binding factor acute myeloid leukemia is actively seeking new participants at 51 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06917911 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 51 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06917911 was last updated 19 hours ago (August 28, 2026). HelloStudys verifies this status automatically.